MetalloBio’s CEO, Dr Michael Murray, will be attending the AMR conference in Basel (25-26th February 2025) https://amr-conference.com. In its 9th edition the conference shall, again, host those involved in all aspects of the innovation that challenges the threat untreatable infections pose. Attended by pharmaceutical companies operating in this market sector and a host of start-ups and SMEs - the conference shall allow MetalloBio to stay up-to-date with AMR innovations and connected to those who are leading the surge of new drugs, better diagnostics and new modalities for overcoming antibiotic resistance. Also represented are antimicrobial specialist CROs, expert advisory groups, AMR investors, regulatory consultancies, policy groups and public sector bodies who work directly with patients who face the very real and increasing risk of losing their lives due to the spread of resistant microbial pathogens.